Alzheimer’s: Search for a Cure

Published on21 SEP 2017

Every 33 seconds. That’s how often a new Alzheimer’s patient will be diagnosed in the US by 2050, adding to millions of existing cases of a disease that as of yet has no cure. But we may have reached an important moment in the science of its treatment, according to Goldman Sachs Research’s Terence Flynn.

As part of a new “Outsiders” video series exploring watch-worthy ecosystems at the edge of today’s investable universe, Flynn explains several trends that could push drug development beyond symptom relief to disease modification.

With 350 active clinical trials and strong venture capital investment, hope for a cure abounds.

- Terence Flynn

Terence Flynn
Lead Analyst, Large Cap US Biotechnology Sector, Goldman Sachs Research